![Guy Nehemya](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Guy Nehemya
Operationeel Directeur bij
GALMED PHARMACEUTICALS LTD.
Vermogen: 16 675 $ op 31-05-2026
Profiel
Mr. Guy Nehemya is a Chief Operating & Data Protection Officer at Galmed Pharmaceuticals Ltd. and a Member at Israel Bar Association.
He received his graduate degree from The College of Management Academic Studies and an MBA from Arison School of Business.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 25-03-2026 | 22.115 ( 0,34% ) | 16 675 $ | 31-05-2026 |
Actieve functies van Guy Nehemya
| Bedrijven | Functie | Begin |
|---|---|---|
| GALMED PHARMACEUTICALS LTD. | Operationeel Directeur | 01-10-2013 |
Israel Bar Association
 Israel Bar Association Miscellaneous Commercial ServicesCommercial Services Provides legal services | Corporate Officer/Principal | 01-01-2012 |
Opleiding van Guy Nehemya
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
87
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Israel Bar Association
Israel Bar Association Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Arison School of Business
 Arison School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The College of Management Academic Studies
 The College of Management Academic Studies Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Galmed Pharmaceuticals Ltd.
 Galmed Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures aramchol for non-alcoholic steatohepatitis | Health Technology |
